Clinical Trials Browser

Interventional × Pelvic Neoplasms × Gastrointestinal × Clear all

Anal Canal Carcinoma, Anus Neoplasms, Pelvic Neoplasms, Uterine Neoplasms, Vaginal Neoplasms

NCT06187103 2025-12-17

Evaluation of Improved Onboard Patient Imaging

Phase NA Active not recruiting

40 enrolled

BreastGastrointestinalGynecologicHead & NeckThoracic

Breast Neoplasms, Gastrointestinal Neoplasms, Head and Neck Neoplasms, Lung Neoplasms, Pelvic Neoplasms

NCT04213794 2025-02-20

TOASTIT

Phase EARLY_PHASE1 Terminated

2 enrolled

GastrointestinalGynecologicOther solid neoplasmSarcomaThoracic

Mesothelioma, Malignant, Colonic Neoplasms, Fallopian Tube Neoplasms, Liposarcoma, Ovarian Neoplasms, Pelvic Neoplasms, Rectal Neoplasms, Rhabdomyosarcoma, Sarcoma, Stomach Neoplasms, Desmoplastic Small Round Cell Tumor

NCT06458725 2024-06-14

PILLAR

Phase NA Not yet recruiting

30 enrolled

GastrointestinalGynecologic

Pelvic Neoplasms, Rectal Neoplasms

NCT04066894 2023-08-14

Sacral Nerve Stimulation in Treating Low Anterior Resection Syndrome or Fecal Incontinence in Patients With Locally Advanced Rectal Cancer or Other Pelvic Cancer, the RESTORE Study

Phase 2 Terminated

3 enrolled 5 charts

GastrointestinalGenitourinaryGynecologic

Low Anterior Resection Syndrome, Anus Neoplasms, Urinary Bladder Neoplasms, Uterine Cervical Neoplasms, Ovarian Neoplasms, Pelvic Neoplasms, Prostatic Neoplasms, Rectal Neoplasms, Uterine Neoplasms, Vaginal Neoplasms, Vulvar Neoplasms

NCT04008537 2022-04-19

Daily Imaging, Target Identification, and Simulated Computed Tomography-Based Stereotactic Adaptive Radiotherapy Workflow in a Novel Ring Gantry Radiotherapy Device

Phase NA Completed

37 enrolled

GastrointestinalGynecologic

Pancreatic Neoplasms, Pelvic Neoplasms

NCT03595722 2019-08-15

Exploring HIFU as a Treatment for Rectal and Other Pelvic Cancers

Phase NA Unknown

60 enrolled

GastrointestinalGynecologic

Uterine Cervical Neoplasms, Pelvic Neoplasms, Rectal Neoplasms, Endometrial Neoplasms

NCT03007771 2017-10-06

Magnetic Resonance-guided High-Intensity Focused Ultrasound (MR-HIFU) Used for Mild Hyperthermia

Phase 1 Withdrawn

GastrointestinalGenitourinaryGynecologicSarcoma

Urinary Bladder Neoplasms, Uterine Cervical Neoplasms, Pelvic Neoplasms, Rectal Neoplasms, Sarcoma

NCT01103492 2015-01-05

Treatment of Hemorrhagic Radiation Proctitis Using the Halo System

Phase NA Completed

1 enrolled 6 charts

GastrointestinalGenitourinaryGynecologic

Gastrointestinal Hemorrhage, Pelvic Neoplasms, Prostatic Neoplasms, Endometrial Neoplasms

NCT00385177 2009-06-04

Phase 1 Dose Escalation Study of SN2310 Injectable Emulsion in Patients With Advanced Solid Tumors

Phase 1 Completed

61 enrolled

BreastGastrointestinalGynecologicThoracic

Breast Neoplasms, Lung Neoplasms, Pancreatic Neoplasms, Pelvic Neoplasms, Colorectal Neoplasms

NCT00028405 2005-06-24

Photodynamic Therapy System for Patients With Refractory/Unresponsive Solid Tumors

Phase 1 Completed

48 enrolled

BreastGastrointestinalGynecologicHead & NeckSarcoma

Lymphadenopathy, Anus Neoplasms, Breast Neoplasms, Uterine Cervical Neoplasms, Head and Neck Neoplasms, Mouth Neoplasms, Neoplasms, Ovarian Neoplasms, Pelvic Neoplasms, Rectal Neoplasms, Recurrence, Sarcoma, Colorectal Neoplasms

Clinical Trials

SAPPHIRE

Evaluation of Improved Onboard Patient Imaging

TOASTIT

PILLAR

Sacral Nerve Stimulation in Treating Low Anterior Resection Syndrome or Fecal Incontinence in Patients With Locally Advanced Rectal Cancer or Other Pelvic Cancer, the RESTORE Study

Daily Imaging, Target Identification, and Simulated Computed Tomography-Based Stereotactic Adaptive Radiotherapy Workflow in a Novel Ring Gantry Radiotherapy Device

Exploring HIFU as a Treatment for Rectal and Other Pelvic Cancers

Magnetic Resonance-guided High-Intensity Focused Ultrasound (MR-HIFU) Used for Mild Hyperthermia

Treatment of Hemorrhagic Radiation Proctitis Using the Halo System

Phase 1 Dose Escalation Study of SN2310 Injectable Emulsion in Patients With Advanced Solid Tumors

Photodynamic Therapy System for Patients With Refractory/Unresponsive Solid Tumors